Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy. Jeanne and Javier, who have been married for 15 years.Credit...Katherine Wolkoff for The New ...
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company's quarterly earnings ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Lilly said on a call with analysts that it still believed there was huge demand for its weight-loss drug Zepbound and diabetes treatment Mounjaro from hundreds of millions of patients. The ...
open image in gallery A small percentage of patients taking weight loss and diabetes drugs like Ozempic and Zepbound have experienced vision loss. However, scientists they there is not an ...